6505-99-211-4300
Clindamycin Hydrochloride Capsules
6505992114300 992114300 DALACINC 0067546 67546 J01F F01
Managed by United Kingdom
NSN Created on 25 Apr 1991
Data Last Changed
January 2023
January 2023
NATO Update Count
1
1
NATO Data Quality
Marketplace 6505-99-211-4300
Need Help?
Request a Quotation from participating marketplace vendors
Request a Quotation from participating marketplace vendors
Related Documents 6505-99-211-4300 5+ Documents (More...)
6505-99-211-4300Clindamycin Hydrochloride Capsules6505992114300 992114300 DALACINC 0067546 67546
J01F F01 Secondary Buy RNCC 5 RNVC 2 DAC 4 67546 K4582 - Pfizer Ltd (Active) Secondary Buy RNCC 5 RNVC
6505-99-211-4300Clindamycin Hydrochloride Capsules6505992114300 992114300 DALACINC 0067546 67546
J01F F01 Secondary Buy RNCC 5 RNVC 2 DAC 4 67546 K4582 - Pfizer Ltd (Active) Secondary Buy RNCC 5 RNVC
6505-99-211-4300Clindamycin Hydrochloride Capsules6505992114300 992114300 DALACINC 0067546 67546
your web browser . 6505-99-211-6332Clindamycin Palmita6505992116332 992116332 DALACIN C PAEDIATRIC J01F F01
| RNVC: 2 | DAC: 4 4 Feb 2000 6505-99-211-6332 https//www.nsnlookup.com /fsg-65/fsc-6505/uk 6505-99-211-4300
Clindamycin Hydrochloride Capsules 992114300 6505-99-211-4300Clindamycin Hydrochloride Capsules6505992114300
| RNVC: 2 | DAC: 4 4 Feb 2000 6505-99-211-6332 https//www.nsnlookup.com /fsg-65/fsc-6505/uk 6505-99-211-4300
Clindamycin Hydrochloride Capsules 992114300 6505-99-211-4300Clindamycin Hydrochloride Capsules6505992114300
99-458-2348Clindamycin Hydrochloride Capsules6505994582348 994582348 DALACIN C 2135903 0032/5007R J01F F01
your web browser . 6505-99-211-6332Clindamycin Palmita6505992116332 992116332 DALACIN C PAEDIATRIC J01F F01
Created on 25 Apr 1991 Data Last 6505-99-211-4300Clindamycin Hydrochloride Capsules6505992114300 992114300
your web browser . 6505-99-211-6332Clindamycin Palmita6505992116332 992116332 DALACIN C PAEDIATRIC J01F F01
Created on 25 Apr 1991 Data Last 6505-99-211-4300Clindamycin Hydrochloride Capsules6505992114300 992114300
Capsules 190013031 211-4300 6505-19-000-6109 6505-33-005-2496 https// -695-8165 6505-01-680-0696 6505-99-211-4300
6505-33-005-2496 131162664 4131 6505-19-001-3031 https//www.nsnlookup.com /fsg-65/fsc-6505/uk 6505-99-211-4300
Clindamycin Hydrochloride Capsules 992114300 Capsules 695-8165 6505-01-680-0696 6505-99-211-4300
6505-33-005-2496 131162664 4131 6505-19-001-3031 https//www.nsnlookup.com /fsg-65/fsc-6505/uk 6505-99-211-4300
Clindamycin Hydrochloride Capsules 992114300 Capsules 695-8165 6505-01-680-0696 6505-99-211-4300
4131Clindamycin Hydrochloride Capsules6505131194131 https//www.nsnlookup.com /fsg-65/fsc-6505/uk 6505-99-211-4300
Clindamycin Hydrochloride Capsules 992114300 Hydrochloride Capsules 695-8165 6505-01-680-0696 6505
Clindamycin Hydrochloride Capsules 190013031 Capsules Hydrochloride Capsules 695-8165 6505-01-680-0696 6505-99-211-4300
Clindamycin Hydrochloride Capsules 992114300 Hydrochloride Capsules 695-8165 6505-01-680-0696 6505
Clindamycin Hydrochloride Capsules 190013031 Capsules Hydrochloride Capsules 695-8165 6505-01-680-0696 6505-99-211-4300
Restrictions 6505-99-211-4300
End Users 6505-99-211-4300
- United Kingdom (ZK)
Approved Sources 6505-99-211-4300
- Part Number
- Manufacturer
- Status
- DALACINC
- Manufacturer
- K4595 - Upjohn Ltd (Obsolete)
- Incomplete Reference
- Incomplete Reference
- 0067546
- K4582 - Pfizer Ltd (Active)
- Secondary Buy
- Secondary Buy
- 67546
- K4582 - Pfizer Ltd (Active)
- Secondary Buy
- Secondary Buy
- J01F F01
- I9022 - Who Collaborating Centre For Drug (Active)
- NATO Reference
- NATO Reference